These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 20428771)

  • 1. BDNF mediated TrkB activation is a survival signal for transitional cell carcinoma cells.
    Huang YT; Lai PC; Wu CC; Hsu SH; Cheng CC; Lan YF; Chiu TH
    Int J Oncol; 2010 Jun; 36(6):1469-76. PubMed ID: 20428771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TrkB antibody elicits cytotoxicity and suppresses migration/invasion of transitional cell carcinoma cells.
    Huang YT; Lai PC; Wu CC; Cheng CC; Chiu TH
    Int J Oncol; 2010 Oct; 37(4):943-9. PubMed ID: 20811716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of BDNF and TrkB in human bladder cancer specimens.
    Lai PC; Chiu TH; Huang YT
    Oncol Rep; 2010 Nov; 24(5):1265-70. PubMed ID: 20878119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of BDNF/TrkB pathway promotes prostate cancer progression via induction of epithelial-mesenchymal transition and anoikis resistance.
    Li T; Yu Y; Song Y; Li X; Lan D; Zhang P; Xiao Y; Xing Y
    FASEB J; 2020 Jul; 34(7):9087-9101. PubMed ID: 32390303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferative role of BDNF/TrkB signaling is associated with anoikis resistance in cervical cancer.
    Yuan Y; Ye HQ; Ren QC
    Oncol Rep; 2018 Aug; 40(2):621-634. PubMed ID: 29989647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain-derived neurotrophic factor/tropomyosin-related kinase B signaling pathway contributes to the aggressive behavior of lung squamous cell carcinoma.
    Ozono K; Ohishi Y; Onishi H; Nakamura K; Motoshita J; Kato M; Nakanishi R; Nakamura M; Oda Y
    Lab Invest; 2017 Nov; 97(11):1332-1342. PubMed ID: 28604655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-1-3p inhibits cell proliferation and invasion by regulating BDNF-TrkB signaling pathway in bladder cancer.
    Gao L; Yan P; Guo FF; Liu HJ; Zhao ZF
    Neoplasma; 2018; 65(1):89-96. PubMed ID: 29322793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fine-tuning roles of endogenous brain-derived neurotrophic factor, TrkB and sortilin in colorectal cancer cell survival.
    Akil H; Perraud A; Mélin C; Jauberteau MO; Mathonnet M
    PLoS One; 2011; 6(9):e25097. PubMed ID: 21966426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain-derived neurotrophic factor and neurotrophin-4/5 are expressed in breast cancer and can be targeted to inhibit tumor cell survival.
    Vanhecke E; Adriaenssens E; Verbeke S; Meignan S; Germain E; Berteaux N; Nurcombe V; Le Bourhis X; Hondermarck H
    Clin Cancer Res; 2011 Apr; 17(7):1741-52. PubMed ID: 21350004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of brain-derived neurotrophic factor/tyrosine kinase B signaling suppresses choriocarcinoma cell growth.
    Kawamura N; Kawamura K; Manabe M; Tanaka T
    Endocrinology; 2010 Jul; 151(7):3006-14. PubMed ID: 20463055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel role for BDNF-TrkB in the regulation of chemotherapy resistance in head and neck squamous cell carcinoma.
    Lee J; Jiffar T; Kupferman ME
    PLoS One; 2012; 7(1):e30246. PubMed ID: 22276165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BDNF/TrkB content and interaction with gastrin-releasing peptide receptor blockade in colorectal cancer.
    Brunetto de Farias C; Rosemberg DB; Heinen TE; Koehler-Santos P; Abujamra AL; Kapczinski F; Brunetto AL; Ashton-Prolla P; Meurer L; Reis Bogo M; Damin DC; Schwartsmann G; Roesler R
    Oncology; 2010; 79(5-6):430-9. PubMed ID: 21474968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain-derived neurotrophic factor/tropomyosin-related kinase B pathway in gastric cancer.
    Okugawa Y; Tanaka K; Inoue Y; Kawamura M; Kawamoto A; Hiro J; Saigusa S; Toiyama Y; Ohi M; Uchida K; Mohri Y; Kusunoki M
    Br J Cancer; 2013 Jan; 108(1):121-30. PubMed ID: 23175149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The secreted brain-derived neurotrophic factor precursor pro-BDNF binds to TrkB and p75NTR but not to TrkA or TrkC.
    Fayard B; Loeffler S; Weis J; Vögelin E; Krüttgen A
    J Neurosci Res; 2005 Apr; 80(1):18-28. PubMed ID: 15704182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression and significance of brain-derived neurotrophic factors and receptors in multiple myeloma].
    Sun CY; Hu Y; Wu T; Wang YD; He WJ
    Zhonghua Nei Ke Za Zhi; 2005 Dec; 44(12):906-9. PubMed ID: 16409727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain-Derived Neurotrophic Factor Regulates Ishikawa Cell Proliferation through the TrkB-ERK1/2 Signaling Pathway.
    Cao M; Niu Q; Xiang X; Yuan C; Iqbal T; Huang Y; Tian M; Zhao Z; Li C; Zhou X
    Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33302387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain-derived neurotrophic factor (BDNF)-induced tropomyosin-related kinase B (Trk B) signaling is a potential therapeutic target for peritoneal carcinomatosis arising from colorectal cancer.
    Tanaka K; Okugawa Y; Toiyama Y; Inoue Y; Saigusa S; Kawamura M; Araki T; Uchida K; Mohri Y; Kusunoki M
    PLoS One; 2014; 9(5):e96410. PubMed ID: 24801982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sunitinib can enhance BCG mediated cytotoxicity to transitional cell carcinoma through apoptosis pathway.
    Ping SY; Wu CL; Yu DS
    Urol Oncol; 2012 Sep; 30(5):652-9. PubMed ID: 20884251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of hydatidiform molar growth by inhibiting endogenous brain-derived neurotrophic factor/tyrosine kinase B signaling.
    Kawamura K; Kawamura N; Kawagoe Y; Kumagai J; Fujimoto T; Terada Y
    Endocrinology; 2012 Aug; 153(8):3972-81. PubMed ID: 22719055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estradiol induces BDNF/TrkB signaling in triple-negative breast cancer to promote brain metastases.
    Contreras-Zárate MJ; Day NL; Ormond DR; Borges VF; Tobet S; Gril B; Steeg PS; Cittelly DM
    Oncogene; 2019 Jun; 38(24):4685-4699. PubMed ID: 30796353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.